Literature DB >> 16495586

Neonatal haemorrhagic conjunctivitis: a specific sign of chlamydial infection.

K Chang1, V Y W Cheng, N S Kwong.   

Abstract

OBJECTIVE: To review the bacteriological causes and clinical features of acute neonatal conjunctivitis in a local paediatric centre.
DESIGN: Retrospective review.
SETTING: Paediatric unit of a regional hospital, Hong Kong. PATIENTS: All neonates who presented to Tuen Mun Hospital from 1 January 1996 to 31 December 2002 with persistent eye discharge and a positive eye swab culture. MAIN OUTCOME MEASURES: Clinical features of neonates with chlamydial and non-chlamydial conjunctivitis.
RESULTS: Of 90 neonates with positive eye swab or conjunctival scraping cultures, Chlamydia trachomatis was the second most common (n=19, 21%) cause of acute neonatal conjunctivitis after Staphylococcus aureus (n=32, 36%). All of the neonates with chlamydial conjunctivitis were delivered vaginally: two of them had concomitant chlamydial pneumonia. Neisseria gonorrhoeae conjunctivitis was rare (n=1, 1%). None of the mothers of neonates with Chlamydia had any history of sexually transmitted disease. The timing of presentation, gestational age, birth weight, and sex of the neonates did not suggest a risk of chlamydial infection. Nonetheless haemorrhagic eye discharge had a specificity of 100% and positive predictive value of 100% for chlamydial infection. There were no adverse ophthalmological consequences or complications of pyloric stenosis in any neonate following treatment with oral erythromycin.
CONCLUSIONS: Haemorrhagic eye discharge is a highly specific sign of neonatal chlamydial conjunctivitis. Early and prompt treatment with oral erythromycin is safe and effective.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16495586

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  8 in total

Review 1.  [Chlamydial diseases of the eye. A short overview].

Authors:  W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

2.  Interventions for preventing ophthalmia neonatorum.

Authors:  Vimal Scott Kapoor; Jennifer R Evans; S Swaroop Vedula
Journal:  Cochrane Database Syst Rev       Date:  2020-09-21

3.  Severe ophthalmia neonatorum in Southwest China: a 5-year review of demographics, microbiological results, and risk factors.

Authors:  Xiao-Jiao Tang; Jia-Tong He; Qing Liu; Xin-Ke Chen; Lin Chen
Journal:  Int Ophthalmol       Date:  2022-01-15       Impact factor: 2.029

4.  Distribution study of Chlamydia trachomatis genotypes in symptomatic patients in Buenos Aires, Argentina: association between genotype E and neonatal conjunctivitis.

Authors:  Lucía Gallo Vaulet; Carolina Entrocassi; Ana I Corominas; Marcelo Rodríguez Fermepin
Journal:  BMC Res Notes       Date:  2010-02-09

5.  A study of Ophthalmia Neonatorum in the Central Reion of Ghana: Causative Agents and Antibiotic Susceptibility Patterns.

Authors:  Samuel Bert Boadi-Kusi; Samuel Kyei; Selina Holdbrook; Emmanuel Kwasi Abu; Jonathan Ntow; Abena Mantebea Ateko
Journal:  Glob Pediatr Health       Date:  2021-05-28

6.  Prevalence of Chlamydia trachomatis Infection and Its Association with Sexual Behaviour and Alcohol Use in the Population Living in Separated and Segregated Roma Settlements in Eastern Slovakia.

Authors:  Ingrid Babinská; Monika Halánová; Zuzana Kalinová; Lenka Čechová; Lýdia Čisláková; Andrea Madarasová Gecková
Journal:  Int J Environ Res Public Health       Date:  2017-12-14       Impact factor: 3.390

Review 7.  Treatment of Neonatal Chlamydial Conjunctivitis: A Systematic Review and Meta-analysis.

Authors:  Andrew Zikic; Holger Schünemann; Teodora Wi; Ornella Lincetto; Nathalie Broutet; Nancy Santesso
Journal:  J Pediatric Infect Dis Soc       Date:  2018-08-17       Impact factor: 3.164

8.  Aetiology of neonatal conjunctivitis evaluated in a population-based setting.

Authors:  Minna Honkila; Marjo Renko; Irma Ikäheimo; Tytti Pokka; Matti Uhari; Terhi Tapiainen
Journal:  Acta Paediatr       Date:  2018-02-06       Impact factor: 2.299

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.